http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11413140-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c5119483c337358c111d788d517b59e4
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0059
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-2409
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-2412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-2427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-2403
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-24
filingDate 2019-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d411509a85ac6ebae33cd91f61c3e8f
publicationDate 2022-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-11413140-B2
titleOfInvention Heart valve prostheses
abstract A prosthetic heart valve includes a prosthetic valve annulus and at least one prosthetic valve leaflet member including at least one coaptation surface configured for cooperating with at least one corresponding coaptation surface of the prosthetic heart valve. At least one valve leaflet member is displaceable by blood flow between a closed position and an open position to produce, correspondingly, a contact and a separation of cooperating coaptation surfaces. In the open position the separation of the cooperating coaptation surfaces enables the blood flow through the orifice in a first direction, and in the closed position the contact of the cooperating coaptation surfaces prevents the blood flow through the orifice in a second direction, opposite to the first direction. The prosthetic heart valve includes at least one device configured for preventing at least in part the contact between cooperating coaptation surfaces, so that a blood regurgitation in the second direction is enabled, wherein the at least one device is configured for ceasing its action after a predetermined amount of time.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021315700-A1
priorityDate 2012-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009276039-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009138078-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007142907-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016008128-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005234541-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011288621-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009164029-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68152
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID866
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23663392
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19660
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450770914
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559376
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556976
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407442396

Total number of triples: 33.